pd 123177 has been researched along with malondialdehyde in 1 studies
| Studies (pd 123177) | Trials (pd 123177) | Recent Studies (post-2010) (pd 123177) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
|---|---|---|---|---|---|
| 142 | 0 | 2 | 27,849 | 1,405 | 13,922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bild, W; Ciobica, A; Hritcu, L; Stefanescu, C | 1 |
1 other study(ies) available for pd 123177 and malondialdehyde
| Article | Year |
|---|---|
Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Avoidance Learning; Behavior, Animal; Captopril; Glutathione Peroxidase; Hippocampus; Imidazoles; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Maze Learning; Memory; Memory, Short-Term; Oxidative Stress; Psychomotor Performance; Pyridines; Rats; Rats, Wistar; Superoxide Dismutase | 2013 |